Actionnariat et activité des initiés pour Curis, Inc. (CRIS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.12 |
| Capitalisation | $2M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $26.0M | $38.3M | $23.6M | $15.4M | $129.6M | $40.0M | $19.7M | $26.7M | $20.0M | $5.1M |
| Placements à Court Terme | $18.4M | $21.9M | $634000 | $5.1M | $38.9M | $75.9M | $66.0M | $29.7M | 0 | 0 |
| Créances | $2.5M | $3.1M | $2.9M | $3.2M | $3.0M | $3.2M | $3.0M | $2.8M | $3.3M | 0 |
| Stocks | -$1.3M | 0 | -$827000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $46.9M | $64.3M | $27.1M | $25.0M | $172.8M | $122.4M | $92.1M | $60.9M | $26.4M | $6.9M |
| Immobilisations Corporelles | $413000 | $366000 | $267000 | $303000 | $7.2M | $6.3M | $5.1M | $3.5M | $3.4M | $2.0M |
| Goodwill | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $57.8M | $73.8M | $37.4M | $35.1M | $204.4M | $162.3M | $108.8M | $77.3M | $41.3M | $20.0M |
| Dettes Fournisseurs | $5.9M | $5.4M | $2.9M | $4.5M | $4.2M | $6.4M | $3.2M | $3.2M | $3.0M | $5.6M |
| Dette à Court Terme | $4.9M | $5.9M | $6.9M | 0 | $557000 | 0 | 0 | 0 | 0 | $1.2M |
| Passifs Courants | $8.6M | $14.1M | $6.4M | $6.5M | $10.1M | $13.4M | $10.0M | $22.0M | $19.0M | $14.1M |
| Dette à Long Terme | $14.9M | $35.7M | $28.6M | 0 | $334000 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $28.5M | $49.8M | $41.9M | $69.0M | $73.7M | $71.6M | $62.3M | $57.6M | $47.3M | $14.5M |
| Réserves | -$898.9M | -$952.3M | -$984.8M | -$1.02B | -$1.05B | -$1.09B | -$1.15B | -$1.20B | -$1.24B | -$1.25B |
| Capitaux Propres | $29.3M | $24.0M | -$4.5M | -$33.9M | $130.7M | $90.7M | $46.6M | $19.7M | -$6.0M | $5.5M |
| Dette Totale | $19.9M | $41.6M | $35.5M | $166000 | $7.7M | $5.0M | $3.9M | $2.8M | $3.0M | $1.6M |
| Dette Nette | -$24.6M | -$18.7M | $11.2M | -$20.4M | -$160.8M | -$110.8M | -$81.7M | -$53.5M | -$17.0M | -$3.4M |
| Fonds de Roulement | $38.3M | $50.2M | $20.8M | $18.5M | $162.7M | $108.9M | $82.1M | $38.9M | $7.4M | -$7.2M |
Santé financière
| Dette / Capitaux propres | 0.22 |
| Ratio de liquidité | 0.49 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -92.32 |
Rentabilité
| Rentabilité des capitaux propres | -1035.26% |
| Rentabilité du capital investi | -567.17% |
| Rentabilité des actifs | -111.51% |
| Marge brute | 99.28% |
| Marge opérationnelle | -833.40% |
| Marge nette | -490.33% |
Entreprises liées: ASBP · ATHA · BCTX · CTXR · ENTO · HOTH · ICU
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CRIS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions